This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jelsbak, L.
Right arrow Articles by Molin, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jelsbak, L.
Right arrow Articles by Molin, S.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Cystic Fibrosis

 Previous Article  |  Next Article 

Infection and Immunity, May 2007, p. 2214-2224, Vol. 75, No. 5
0019-9567/07/$08.00+0     doi:10.1128/IAI.01282-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Molecular Epidemiology and Dynamics of Pseudomonas aeruginosa Populations in Lungs of Cystic Fibrosis Patients{triangledown}

Lars Jelsbak,1 Helle Krogh Johansen,2,3 Anne-Louise Frost,1 Regitze Thøgersen,1 Line E. Thomsen,4 Oana Ciofu,3 Lei Yang,1 Janus A. J. Haagensen,1 Niels Høiby,2,3 and Søren Molin1*

Infection Microbiology Group, BioCentrum-DTU, Technical University of Denmark, Lyngby, Denmark,1 Copenhagen CF Center, Department of Clinical Microbiology, Rigshospitalet,2 Institute of Medical Microbiology and Immunology, Panum Institute, University of Copenhagen, Copenhagen, Denmark,3 Department of Veterinary Pathobiology, The Royal Veterinary and Agricultural University, DK-1870 Frederiksberg C, Denmark4

Received 10 August 2006/ Returned for modification 31 October 2006/ Accepted 16 January 2007

The ability to establish lifelong persistent infections is a fundamental aspect of the interactions between many pathogenic microorganisms and their mammalian hosts. One example is chronic lung infections by the opportunistic pathogen Pseudomonas aeruginosa in cystic fibrosis (CF) patients. This infection process is associated with extensive genetic adaptation and microevolution of the infecting bacteria. Through investigations of P. aeruginosa populations and infection dynamics in a group of CF patients followed at the Danish CF Clinic in Copenhagen, we have identified two distinct and dominant clones that have evolved into highly successful colonizers of CF patient airways. A significant component of the evolutionary success of these two clones has been their efficient transmissibility among the CF patients. The two clones have been present and transmitted among different CF patients for more than 2 decades. Our data also suggest that the P. aeruginosa population structure in the CF patient airways has been influenced by competition between different clones and that the two dominant clones have been particularly competitive within the lungs, which may add to their overall establishment success. In contrast, we show that adaptive traits commonly associated with establishment of chronic P. aeruginosa infections of CF patients, such as transition to the mucoid phenotype and production of virulence factors, play minor roles in the ability of the two dominant clones to spread among patients and cause long-term chronic infections. These findings suggest that hitherto-unrecognized evolutionary pathways may be involved in the development of successful and persistent P. aeruginosa colonizers of CF patient lungs.


* Corresponding author. Mailing address: Infection Microbiology Group, BioCentrum-DTU, Technical University of Denmark, Building 301, 2800 Lyngby, Denmark. Phone: 45 4525 2513. Fax: 45 4588 7328. E-mail: sm{at}biocentrum.dtu.dk

{triangledown} Published ahead of print on 29 January 2007.

Editor: V. J. DiRita


Infection and Immunity, May 2007, p. 2214-2224, Vol. 75, No. 5
0019-9567/07/$08.00+0     doi:10.1128/IAI.01282-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Waine, D. J., Honeybourne, D., Smith, E. G., Whitehouse, J. L., Dowson, C. G. (2009). Cross-Sectional and Longitudinal Multilocus Sequence Typing of Pseudomonas aeruginosa in Cystic Fibrosis Sputum Samples. J. Clin. Microbiol. 47: 3444-3448 [Abstract] [Full Text]  
  • Bragonzi, A., Paroni, M., Nonis, A., Cramer, N., Montanari, S., Rejman, J., Di Serio, C., Doring, G., Tummler, B. (2009). Pseudomonas aeruginosa Microevolution during Cystic Fibrosis Lung Infection Establishes Clones with Adapted Virulence. Am. J. Respir. Crit. Care Med. 180: 138-145 [Abstract] [Full Text]  
  • Mikkelsen, H., Bond, N. J., Skindersoe, M. E., Givskov, M., Lilley, K. S., Welch, M. (2009). Biofilms and type III secretion are not mutually exclusive in Pseudomonas aeruginosa. Microbiology 155: 687-698 [Abstract] [Full Text]  
  • Yang, L., Haagensen, J. A. J., Jelsbak, L., Johansen, H. K., Sternberg, C., Hoiby, N., Molin, S. (2008). In Situ Growth Rates and Biofilm Development of Pseudomonas aeruginosa Populations in Chronic Lung Infections. J. Bacteriol. 190: 2767-2776 [Abstract] [Full Text]  
  • Ciofu, O., Lee, B., Johannesson, M., Hermansen, N. O., Meyer, P., Hoiby, N., the Scandinavian Cystic Fibrosis Study Consortium, (2008). Investigation of the algT operon sequence in mucoid and non-mucoid Pseudomonas aeruginosa isolates from 115 Scandinavian patients with cystic fibrosis and in 88 in vitro non-mucoid revertants. Microbiology 154: 103-113 [Abstract] [Full Text]  
  • Vu-Thien, H., Corbineau, G., Hormigos, K., Fauroux, B., Corvol, H., Clement, A., Vergnaud, G., Pourcel, C. (2007). Multiple-Locus Variable-Number Tandem-Repeat Analysis for Longitudinal Survey of Sources of Pseudomonas aeruginosa Infection in Cystic Fibrosis Patients. J. Clin. Microbiol. 45: 3175-3183 [Abstract] [Full Text]